Back to Search Start Over

Targeted manipulation of m 6 A RNA modification through CRISPR-Cas-based strategies.

Authors :
Sun X
Wang DO
Wang J
Source :
Methods (San Diego, Calif.) [Methods] 2022 Jul; Vol. 203, pp. 56-61. Date of Electronic Publication: 2022 Mar 17.
Publication Year :
2022

Abstract

N <superscript>6</superscript> -methyladenosine (m <superscript>6</superscript> A) is a reversible and prevalent internal modification in RNAs and can be dynamically modulated by methyltransferase and demethylase. Targeted manipulation of m <superscript>6</superscript> A RNA modification is critical in studying the functions of specific m <superscript>6</superscript> A sites as well as developing molecular therapies through targeting m <superscript>6</superscript> A. The CRISPR-Cas systems including CRISPR-Cas9 and CRISPR-Cas13 have been widely used to edit and modify specific nucleotides on DNA and RNA through fusing effective proteins such as enzymes with Cas9/13. Through taking advantage of the m <superscript>6</superscript> A methyltransferase and demethylase, a series of CRISPR-Cas-based methods have also been developed to manipulate the m <superscript>6</superscript> A methylation at specific RNA sites. This review summarizes the latest CRISPR-Cas13 and Cas9 toolkits for m <superscript>6</superscript> A site-specific manipulation, including fundamental components, on-target efficiency, editing window, PAM/PFS requirement, and subcellularly localized targeting as well as potential limitations. We thus aim to provide an overview to assist researchers to choose an optimal tool to manipulate m <superscript>6</superscript> A for different purposes and also point out possible optimization strategies.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1095-9130
Volume :
203
Database :
MEDLINE
Journal :
Methods (San Diego, Calif.)
Publication Type :
Academic Journal
Accession number :
35306148
Full Text :
https://doi.org/10.1016/j.ymeth.2022.03.006